Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z

Sin Nombre virusNational Center for Infectious Diseases
Special Pathogens Branch
All About Hantaviruses
 All About Hantaviruses Home | General Information
Technical Information | Contact Us
Site Contents
General Information
Technical Information
State Contacts
Case Information
Teaching Materials

Epidemiology of HPS Slideset

HPS Teaching Slideset
    Slides 1-13:
General
    Slides 14-25:
Clinical, Diagnosis, and Pathology
    Slides 26-28:
Epidemiology
    Slides 29-37:
Prevention
    Slides 38-43:
Surveillance
Images of HPS Campaigns (on SPB web page)
Prevention Card
Materials by Mail (on SPB web page)
Clinical Update '99 Video (on SPB web page)
Research and Resources
Hantavirus in South and Central America
Previous Feature Articles Archive
Glossary of Terms
Go To...
Special Pathogens Branch Web Page
NCID Home
CDC Home

HPS Teaching Slideset
Slides 26-28: Epidemiological Studies

slides 1-13    slides 14-25    slides 26-28    slides 29-37    slides 38-43 

Download or view complete slideset as a PowerPoint Show

Slide 26: Rodent Exposure
Slide 26
Rodent Exposure
70 Confirmed HPS cases

Rodent Exposure Data from 70 confirmed HPS Cases: A review of confirmed HPS cases was conducted to characterize rodent exposure. Of 70 confirmed HPS cases, 69% had peridomestic exposure; 19% had both peridomestic and occupational exposure; 9% had peridomestic and recreational exposure; 4% had occupational exposure; and 9% had rodent exposure while entering and cleaning rodent-infested structures.

Slide 27: Prevalence of SNV IgG Antibodies in Select U.S. Populations
Slide 27
Prevalence of SNV IgG Antibodies in 
Select U.S. Populations

Seroprevalence of SNV IgG Antibodies in Select U.S. Populations: Studies focusing on select high-risk groups showed a total prevalence of SNV antibodies of 0.6% (15/2531). Antibody prevalence was 0% (0/143) for forest workers; 0% (0/396) for health care workers; 1% (3/299) for prodromal HPS patients during initial 1993 outbreak; 1.3% (3/239) for contacts of HPS patients; 0.2% (1/522) for rural OCC; and .9% (8/932) for rodent workers.
Slide 27
Slide 28
Prevalence of SNV IgG Antibodies in
Select South American Populations

Prevalence of SNV IgG Antibodies in Select South American Populations: Prevalence of hantavirus antibodies in select South American populations varies from region to region. Studies demonstrated an antibody prevalence of 12.8% (44/345) in Paraguay; 40.4% (78/193) among an Indian population in Western Paraguay; <1% in Argentina; 17.1 % (38/222) among an Indian population in the Salta province, Argentina; and 2-13% in Chile.


slides 1-13    slides 14-25    slides 26-28    slides 29-37    slides 38-43 

Download or view complete slideset as a PowerPoint Show

 All About Hantaviruses Home | General Information | Technical Information | Contact Us

CDC Home | Search | Health Topics A-Z | Accessibility

This page last reviewed Friday, June 18, 2004

Special Pathogens Branch
Division of Viral and Rickettsial Diseases
National Center for Infectious Diseases
Centers for Disease Control and Prevention
U.S. Department of Health and Human Services
cdclogos.gif (325 bytes)dhhss.gif (430 bytes)